Desloratadine Market Growing at a CAGR of 5.81% During Forecast 2020-2025

January 8, 2021
Blessy

Desloratadine Market size is forecast to reach 930 million by 2025, growing at a CAGR of 5.81% during the forecast period 2020-2025. Desloratadine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes, sneezing, hives, and itching. An increase in the incidence of allergic rhinitis and nasal congestion are the major factors driving the growth of the market. An increase in the usage of desloratadine in adults and children to relieve hay fever and allergy symptoms is set to further enhance the overall market demand of desloratadine during the forecast period 2020-2025.

Key Takeaways

  • North America dominated the desloratadine market in 2019 owing to the increase in many allergic rhinitis patients. The Desloratadine Market scope for different regions will be provided in the final report.
  • Increasing number of urticaria patients and increasing usage to stop the effects of histamine is likely to aid in the market growth of desloratadine market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Desloratadine Market report.
  • Gastrointestinal disturbance and side effects like fatigue are set to create hurdles for the Desloratadine Market.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=501928

Report Price: $ 4500 (Single User License)  

Geography – Segment Analysis

North America dominated the desloratadine market in 2019 with a share of more than 38.71%, followed by Europe owing to the increasing number of allergic rhinitis patients. Increasing usage of desloratadine to treat skin hives and itching in people with chronic skin reactions is increasing the growth of the desloratadine market in this region.

However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the increasing number of chronic idiopathic urticaria patients. Increasing usage of desloratadine in maintenance therapy or monotherapy is increasing the growth of the desloratadine market in this region.

Drivers – Desloratadine Market 

  • Increase in the number of allergic rhinitis and  nasal congestion patients 
  • Increasing incidence of chronic reactions

Desloratadine Industry Outlook

Desloratadine, the top 10 companies are Abbott Laboratory, Apollo Pharmaceuticals, GlaxoSmithKline Plc, Mayne Pharma Inc, Mylan N V, Pfizer Inc, Schering Plough Corporation, Abbot, Takeda Pharmaceutical Company Ltd, and Teva Pharmaceutical Industry Ltd among others.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Article Categories:
BUSINESS

Leave a Comment